Related Experiment Video
Updated: May 7, 2026

07:07
A High-throughput Method for Measurement of Glomerular Filtration Rate in Conscious Mice
Published on: May 10, 2013
43.4K
GFRAL Is Widely Distributed in the Brain and Peripheral Tissues of Mice
Karoline Fichtner1, Hermann Kalwa1, Miao-Miao Lin1
1Rudolf Boehm Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Leipzig, D-04103 Leipzig, Germany.
Nutrients
|March 13, 2024
Summary
Glial cell-derived neurotrophic factor receptor alpha-like (GFRAL) is more widespread than previously thought. This finding helps explain the diverse effects of growth differentiation factor 15 (GDF15) and may aid in developing new therapies for eating disorders.
Area of Science:
- Neuroscience
- Cell Biology
- Endocrinology
Background:
- The glial cell-derived neurotrophic factor receptor alpha-like (GFRAL) was initially reported to be exclusively expressed in the mouse brainstem's area postrema (AP) and nucleus tractus solitarii (NTS).
- This restricted expression pattern contrasted with the widespread distribution and pleiotropic effects of its ligand, growth differentiation factor 15 (GDF15).
Purpose of the Study:
- To re-evaluate and detail the expression pattern of GFRAL in mice.
- To investigate the discrepancy between the reported localized GFRAL expression and the widespread GDF15 effects.
Main Methods:
- Detailed immunohistochemical analysis of GFRAL expression in various regions of the mouse brain and peripheral tissues.
Main Results:
- GFRAL-immunoreactivity was observed in regions beyond the AP/NTS, including the prefrontal cortex, hippocampus, and nucleus arcuatus.
- GFRAL was also detected in peripheral tissues such as the liver, small intestine, fat, kidney, and muscle.
- This study provides evidence for a more widespread distribution of GFRAL than previously documented.
Conclusions:
- The widespread expression of GFRAL supports its role in mediating the diverse effects of GDF15.
- These findings may offer new insights for developing pharmacological therapies for conditions like obesity, cachexia, and eating disorders.

